These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice. Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y. J Pharm Pharmacol; 2006 Dec 01; 58(12):1629-38. PubMed ID: 17331327 [Abstract] [Full Text] [Related]
10. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Tang FT, Cao Y, Wang TQ, Wang LJ, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ. Eur J Pharmacol; 2011 Jan 10; 650(1):275-84. PubMed ID: 20854809 [Abstract] [Full Text] [Related]
16. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A. Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412 [Abstract] [Full Text] [Related]
18. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Li K, Yao W, Zheng X, Liao K. Cell Res; 2009 Aug 25; 19(8):1006-17. PubMed ID: 19546885 [Abstract] [Full Text] [Related]